FKBP9P1
Putative FK506-binding protein 9-like protein
Also known as: FKB9L_HUMAN
Protein identityUniProt · HPA
OverviewNCBI Gene
No narrative summary is available for FKBP9P1 in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
142 residues, UniProt reviewed canonical sequence.
>Q75LS8|FKBP9P1
1 MDMGLREMCV GEKRTVIIPP HLGYGEAGVD GEVPGSAVLV FDIELLELVA GLPEGYMFIW
61 NGEVSPNLFE EIDKDGNGEV LLEEFSEYIH AQVASGKGKL APGFDAELIV KNMFTNQDRN
121 GDGKVTAEEF KLKDQEAKQD ELLocalizationUniProt · AlphaFold · HPA
Whether an antibody against FKBP9P1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.4
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads FKBP9P1 as an antibody target. Whether an autoantibody or antibody against FKBP9P1 could matter depends on whether native FKBP9P1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
FKBP9P1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label FKBP9P1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...